Skip to content
Screener

Bausch + Lomb BLCO Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$14M-7.9%
Glaukos logo
GlaukosGKOS
$9.52M+166%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
-$480K-115%
HRO
HarrowHROW
$21.72M+11.5%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$70.36M-65.9%

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total equity$6.4B-1.0%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
CapEx$71.0M-20.2%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$5.84B+17.0%
Enterprise value$10.54B+8.9%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Bausch + Lomb’s 10-Q, filed April 29, 2026.

Filed
Apr 29, 2026, 4:36 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001860742-26-000062
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Proceeds from exercise of stock options2
Net cash (used in) provided by financing activities(20)31
Effect of exchange rate changes on cash and cash equivalents and restricted cash9
Net decrease in cash and cash equivalents and restricted cash(118)(101)
Cash and cash equivalents and restricted cash, beginning of period397316
Cash and cash equivalents and restricted cash, end of period$279$215
Non-cash Investing Activities
Accrued purchases of property, plant and equipment$42$52

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's net change in cash?
Bausch + Lomb (BLCO) reported net change in cash of -$118M in Q1 2026.
How has Bausch + Lomb's net change in cash changed year-over-year?
Bausch + Lomb's net change in cash decreased by 16.8% year-over-year, from -$101M to -$118M.
What is the long-term trend for Bausch + Lomb's net change in cash?
Over 2 years (2023 to 2025), Bausch + Lomb's net change in cash has grown at a 32.7% compound annual growth rate (CAGR), from -$46M to $81M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Bausch + Lomb's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude